Monthly Multi-Institutional Hematopathology Interesting Case Conference
The Multi-Institutional Hematopathology Interesting Case Conference (MHICC) is a monthly virtual CME meeting to provide a platform for oncologists, pathologists, and trainees from leading institutions across North America to collaboratively discuss complex and educational hematopathology cases. This interactive and case-based discussion forum offers a unique opportunity to engage with experts, review complex cases, and strengthen interdisciplinary collaboration in hematopathology.
View Participating Institutions
Schedule for 2026 MHICC
| Date | Presenting Institution |
|---|---|
| January 21 | Fox Chase Cancer Center |
| February 25 | National institutes of Health (NIH) |
| March 11 | Mount Sinai |
| April 22 | MSKCC |
| May 27 | Cleveland Clinic |
| June 24 | Weill Cornell Medical College |
| July 29 | Duke University |
| September 30 | University of Pennsylvania |
| October 28 | New York University |
| November 18 | Mass General Brigham |
| December 16 | Emory University |
Upcoming Session
Date: Wednesday, November 18, 2026
Time: 5:00PM (EST)
Presenting Institution: Mass General Brigham
To Access the Meeting:
Please note: the link will only be activated shortly before the meeting begins.
- Click here
- Sign-in with your EMAIL and click “Next”
- Enter your personal information and click “Sign in Now”
- Click “Watch this Lecture Remotely” to enter the meeting
Cases:
Case 1: 82-year-old male patient with a history of prostate adenocarcinoma and a severe eczematous reaction (~70% BSA), previously biopsied on abdomen as consistent with eczema. The severe eczematous eruption (diffuse erythema and exfoliative scaling on the trunk and extremities with facial sparing) is persistent while on dupilumab; the right shoulder is punch biopsied. Case Pathology Slides (H&E sections, and CD3/TRBC1 dual stain; CD3: red; TRBC1: brown).
Case 2: A 62-year-old male patient with a history of diffuse large B-cell lymphoma, GCB-subtype, was initially diagnosed in 2020 with a bulky 17 cm retroperitoneal mass, received multiple lines of therapy and achieved remission. In August 2026, he presented with cutaneous lesions on the lower extremity (pretibial, calf) and a left tongue mass.Case Pathology Slides from the tongue mass biopsy: H&E, CD3/TRBC1 dual stain (CD3: red; TRBC1: brown), CD4, and CD8.
Case 3: 64-year-old male patient with a history of hypertension, GERD, fatty liver, and chronic sinusitis, who presented to his primary care provider with fatigue, shortness of breath, cough, night sweats and easy bruising. He was found to have pancytopenia (WBC 1.9 K/uL, hemoglobin 8.5 g/dL, MCV 100.4 fL, platelets 19 K/uL). A bone marrow biopsy was performed. Case Pathology Slides (Aspirate smear, MPO cytochemical stain, core biopsy H&E, Giemsa, CD34 and CD117/GATA1 dual stain [CD117: brown; GATA1: red]).
Click here to view previous MHICC Cases and Presentations
Educational Objectives:
By participating in this monthly conference, attendees will be able to:
- Discuss key concepts related to hematopathology including flow cytometry, broadly-defined molecular, cytogenetic and clinical findings as well as therapeutic implications.
- Identify and analyze challenging hematologic neoplasms, applying updated diagnostic criteria and emerging recommendations to improve patient outcome.
- Integrate novel diagnostic modalities and recent advancements in hematopathology to enhance diagnostic accuracy and facilitate more precise clinical decision-making.
Target Audience:
The MHICC is designed for a diverse audience of healthcare professionals with an interest in hematopathology and related fields. This includes, but is not limited to:
- Pathologists, as well as Medical and Radiation Oncologists
- Fellows, Residents, and Trainees in Pathology, Hematopathology, Molecular Pathology, Hematologic Oncology, and Radiation Oncology
Participating Institutions and Organizing Committee Members:
Cleveland Clinic - Megan Nakashima, MD and Anna B. Owczarczyk, MD, PhD
Duke University - Elena M. Fenu, MD; Wendy Lin, MD, PhD; and Danielle Maracaja, MD
Emory University - Brooj Abro, MD and David L. Jaye, MD
Fox Chase Cancer Center - Nicholas Mackrides, MD; Mariusz Wasik, MD; Reza Nejati, MD; Rashmi Khanal, MD and Anthony Stack, DO
Icahn School of Medicine at Mount Sinai - Shafinaz Hussein, MD
Mass General Brigham - Sam Sadigh, MD
Memorial Sloan Kettering Cancer Center - Pallavi Kanwar, MD and Alexander Chan, MD
National Institutes of Health (NIH) - Katherine Calvo, MD, PhD
NYU Grossman School of Medicine - Nicholas Ward, MD
University of Pennsylvania - Siddharth Bhattacharyya, MD
University of Toronto - Ali Sakhdari, MD, MSc.
Weill Cornell Medicine - Sanjay Patel, MD
For more information, please contact Reza Nejati, MD, Chair of the Organizing Committee, at Reza.Nejati@fccc.edu.
CME Information and Credit Instructions
To Access your CME Certificate:
After the meeting, you’ll receive an email prompting you to complete a brief evaluation. Once submitted, your credit certificate will be available for download—please remember to save it for your records.
Accreditation Statement:
Temple Health is accredited by the Pennsylvania Medical Society to provide continuing medical education for physicians.
Credit Designation:
Temple Health designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the educational activity.
If you have any questions regarding CME credits, please don’t hesitate to reach out to Lucía Tono at Lucia.Tono-Ramirez@tuhs.temple.edu.